Fundamental Disease Challenges Tackled Through
Intelligent Genetic Programming

Our Gene Circuit Solutions

senti-gene-circuit-icons-logic

Logic Gating

Integrates multiple targets to pinpoint diseased cells and spare healthy ones

senti-gene-circuit-icons-multi

Multi-Arming

Targets multiple disease pathways within a single all-in-one drug

watch video

senti-gene-circuit-icons-dial

Regulator Dial

Dynamically regulates therapies in vivo using FDA-approved oral drugs

watch video

senti-gene-circuit-icons-sensor

Smart Sensor

Precisely detects and responds to
disease environments

watch video

Logic Gates in Cell Therapy

Enable CAR-NK / CAR-T Cells to Address Broad Liquid and Solid Tumor Applications

Approach-Gene-Circuit-Technology-Platform-_Logic-Gates-in-Cell-Therapy

Logic Gate Technology Has the Potential to Expand Addressable Cancer Indications, Particularly in Solid Tumors

Approach_Overview_Logic-Gate-Technology-Has-the-Potential-to-Expand-Addressable-Cancer-Indications-Particularly-in-Solid-Tumors-v2
ADC: antibody-drug conjugate; TCE: T-cell engager; 1. Kwon Nature 2023; 2. Dannenfelser Cell Systems 2020; 3. Solid tumors market estimated to reach US$ 375.4 billion by 2034, impelled by widespread adoption of targeted therapy. BioSpace. (2024, July 19)